BioXcel Therapeutics Inc (FRA:BX2)
€ 0.5724 0.0254 (4.64%) Market Cap: 25.17 Mil Enterprise Value: 68.70 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 18/100

Q4 2018 BioXcel Therapeutics Inc Earnings Call Transcript

Mar 07, 2019 / 01:30PM GMT
Release Date Price: €7.22 (-5.62%)
Operator

Good day, and welcome to the BioXcel Therapeutics Fourth Quarter and Full Year 2018 Results Conference Call and Audio Webcast. Today's conference is being recorded.

At this time, I'd like to turn the conference over to Carol Ruth of The Ruth Group. Please go ahead.

Carol A. Ruth
The Ruth Group, Inc. - Founder and CEO

Thank you, operator. Just to remind everyone, certain matters discussed on today's conference call or answers that may be given to questions asked are forward-looking statements that are subject to risks and uncertainties relating to future events and/or the future financial performance of the company. Actual results could differ materially from those anticipated in these forward-looking statements. The risk factors that may affect results are detailed in the company's most recent filings with the U.S. Securities and Exchange Commission, which can be found on our website at www.bioxceltherapeutics.com or on

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot